Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and G&agr;q Overexpression–Induced Heart Failure

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation Research

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1161/CIRCRESAHA.110.232306PMID 21311045PMCID PMC3785241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac Myocytes

  2010cited by this paper
• Methods in mammalian autophagy research.

  2010cited by this paper
• Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging

  2009cited by this paper
• Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans.

  2009cited by this paper
• Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy

  2009cited by this paper
• DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice

  2008cited by this paper
• DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice

  2008cited by this paper
• Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells

  2008cited by this paper
• Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.

  2008cited by this paper
• Why have antioxidants failed in clinical trials?

  2008cited by this paper
• Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy

  2007cited by this paper
• Abstract 1229: Molecular Mechanisms of Angiotensin II-Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction

  2007cited by this paper
• Direct Interaction and Reciprocal Regulation between ASK1 and Calcineurin-NFAT Control Cardiomyocyte Death and Growth

  2006cited by this paper
• EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.

  2006cited by this paper
• Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

  2006cited by this paper
• Mitochondria-Derived Reactive Oxygen Species and Vascular MAP Kinases: Comparison of Angiotensin II and Diazoxide

  2005cited by this paper
• Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury

  2005cited by this paper
• Mitochondria, oxidants, and aging.

  2005cited by this paper
• Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging

  2005cited by this paper
• Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria

  2005cited by this paper
• Premature ageing in mice expressing defective mitochondrial DNA polymerase

  2004cited by this paper
• Mitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency

  2004cited by this paper
• Left ventricular hypertrophy: the next treatable, silent killer?

  2004cited by this paper
• Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.

  2004cited by this paper
• Mitochondrial respiratory-chain diseases.

  2003cited by this paper
• Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling

  2002cited by this paper
• Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice

  2002cited by this paper
• Role of TLR-2 in the Activation of Nuclear Factor κB by Oxidative Stress in Cardiac Myocytes*

  2001cited by this paper
• Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure.

  2001cited by this paper
• Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy

  2001cited by this paper
• Gonadotropin regulation of glutathione synthesis in the rat ovary.

  2001cited by this paper
• Molecular Mechanisms of Human Hypertension

  2001cited by this paper
• Cellular and Subcellular Localization of Catalase in the Heart of Transgenic Mice

  2000cited by this paper
• Stimulation of “Stress-regulated” Mitogen-activated Protein Kinases (Stress-activated Protein Kinases/c-Jun N-terminal Kinases and p38-Mitogen-activated Protein Kinases) in Perfused Rat Hearts by Oxidative and Other Stresses*

  1998cited by this paper
• Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

  1997cited by this paper
• Transgenic Gαq overexpression induces cardiac contractile failure in mice

  1997cited by this paper
• Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements.

  1997cited by this paper
• Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice (*)

  1996cited by this paper
• Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.

  1991cited by this paper
• Mitochondrial Autophagy and Injury in the Liver in Alpha-1-antitrypsin Deficiency

  year unknowncited by this paper

• From Gynecological Endocrine Disorders to Cardiovascular Risk: Insights from Rat Models

  2025cites this paper
• Natural products and ferroptosis: A novel approach for heart failure management.

  2025cites this paper
• Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions

  2025cites this paper
• Serum soluble transferrin receptor (sTfR) in HFpEF: associations with cardiac function and exercise tolerance

  2025cites this paper
• LONP1 regulation of mitochondrial protein folding provides insight into beta cell failure in type 2 diabetes

  2025cites this paper
• ABCC9 knockdown attenuates isoproterenol-induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway

  2025cites this paper
• Targeting the non-neuronal cholinergic machinery: A novel approach to mitigate cardiac aging.

  2025cites this paper
• SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in Gαq-mice

  2025cites this paper
• Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2

  2025cites this paper
• FGF21-FGFR1 signaling protects against cardiac hypertrophy by regulating PINK1-mediated mitophagy pathway.

  2025cites this paper
• Modulation of PPAR‐α and PPAR‐γ Influences Cardiomyocyte Growth and Cardiac Remodeling

  2025cites this paper
• The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC

  2025cites this paper
• Interaction between mitochondrial oxidative stress and myocardial fibrosis in the context of diabetes

  2025cites this paper
• Dysregulated Redox Signaling and Its Impact on Inflammatory Pathways, Mitochondrial Dysfunction, Autophagy and Cardiovascular Diseases

  2025cites this paper
• Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases (Review)

  2025cites this paper
• Mechano-energetic uncoupling in heart failure

  2025cites this paper
• SBK3 suppresses angiotensin II-induced cardiac hypertrophy by regulating mitochondrial metabolism

  2025cites this paper
• Regulatory role of vitamin D3 on myogenesis and fibrogenesis under Vdr gene silencing and TGF-β1 stimulation in skeletal muscle cells

  2025cites this paper
• Mitochondrial DNA Dysfunction in Cardiovascular Diseases: A Novel Therapeutic Target

  2025cites this paper
• Mitochondrial Dysfunction in Cardiovascular Diseases

  2025cites this paper
• Mitochondrial medicine: “from bench to bedside” 3PM-guided concept

  2025cites this paper
• Exploring the Pathogenesis and Traditional Chinese Medicine Therapy of Chronic Heart Failure Based on the Theory of “Interdependence of Qi and Blood” and Mitophagy

  2025cites this paper
• Soluble Guanylate Cyclase Stimulator Vericiguat Attenuates Angiotensin II-Induced Oxidative Stress and Cardiac Remodeling.

  2025cites this paper
• Reduced Expression of UPRmt Proteins HSP10, HSP60, HTRA2, OMA1, SPG7, and YME1L Is Associated with Accelerated Heart Failure in Humans

  2025cites this paper
• Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II

  2025cites this paper
• Mitochondrial quality control: Biochemical mechanism of cardiovascular disease.

  2025cites this paper
• Autophagy fine-tuning by angiotensin-(1-9) in cultured rat cardiomyocytes

  2025cites this paper
• Cardiac-specific overexpression of serum response factor regulates age-associated decline in mitochondrial function

  2025cites this paper
• Circ-0001283 Aggravates Cardiac Hypertrophy by Targeting Myosin Light Chain 3 Protein

  2025cites this paper
• The mechanism of lncRNA PVT1 targeting the miR-30a/Beclin-1 axis to mediate ventricular remodeling in spontaneously hypertensive rats.

  2025cites this paper
• Oxidative Stress, Mitochondrial Homeostasis, and Sirtuins in Atrial Fibrillation

  2025cites this paper
• Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues.

  2025cites this paper
• Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.

  2025cites this paper
• Mechanism of ferroptosis in heart failure: The role of the RAGE/TLR4-JNK1/2 pathway in cardiomyocyte ferroptosis and intervention strategies.

  2025cites this paper
• Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: Interlocking biology between eNOS activity and L-arginine metabolism.

  2024cites this paper
• Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus

  2024cites this paper
• Role of AMPK and Sirtuins in Aging Heart: Basic and Translational Aspects

  2024cites this paper
• "Unravelling the impacts of climatic heat events on cardiovascular health in animal models".

  2024cites this paper
• Mitochondrial Ca2+ Uniporter–Dependent Energetic Dysfunction Drives Hypertrophy in Heart Failure

  2024cites this paper
• Evaluating sex-specific responses to western diet across the lifespan: impact on cardiac function and transcriptomic signatures in C57BL/6J mice at 530 and 640/750 days of age

  2024cites this paper
• Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review

  2024cites this paper
• Oxidative stress and atrial fibrillation.

  2024cites this paper
• Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact.

  2024cites this paper
• Mitochondrial calcium in cardiac ischemia/reperfusion injury and cardioprotection

  2024cites this paper
• An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress

  2024cites this paper
• Mitochondrial complex-1 as a therapeutic target for cardiac diseases

  2024cites this paper
• Modulation of Angiotensin II–Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• The potential roles of exosomes in pathological cardiomyocyte hypertrophy mechanisms and therapy: A review

  2024cites this paper
• Circular RNAs: a small piece in the heart failure puzzle

  2024cites this paper
• Mechanism of Astragalus membranaceus (Huangqi, HQ) for treatment of heart failure based on network pharmacology and molecular docking

  2024cites this paper
• Reactive oxygen species in hypertension

  2024cites this paper
• Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment

  2024cites this paper
• Incidental finding of MELAS in a young woman with decompensated heart failure and end stage kidney disease: a case report

  2024cites this paper
• Investigating the risk factors of cardiomyopathy in pregnant mothers.

  2024cites this paper
• Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy

  2023cites this paper
• Redox imbalance in patients with heart failure and ICD/CRT-D intervention. Can it be an underappreciated and overlooked arrhythmogenic factor? A first preliminary clinical study

  2023cites this paper
• A new application of nano-selenium: rescue of CK2 and mitochondria from oxidative stress to prevent cardiac hypertrophy.

  2023cites this paper
• The role of captopril in leukotriene deficient type 1 diabetic mice

  2023cites this paper
• OXIDATIVE STRESS AND ENDOPLASMIC RETICULAR STRESS INTERPLAY IN THE VASCULOPATHY OF HYPERTENSION.

  2023cites this paper
• Vascular injury associated with ethanol intake is driven by AT1 receptor and mitochondrial dysfunction

  2023cites this paper
• Upregulation of mitochondrial telomerase reverse transcriptase mediates the preventive effect of physical exercise on pathological cardiac hypertrophy via improving mitochondrial function and inhibiting oxidative stress.

  2023cites this paper
• Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure.

  2023cites this paper
• Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection

  2023cites this paper
• ADP-ribosylation: an emerging direction for disease treatment.

  2023cites this paper
• Autophagy in Heart Failure: Insights into Mechanisms and Therapeutic Implications

  2023cites this paper
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

  2023cites this paper
• Mechanism of fibroblast growth factor 21 in cardiac remodeling

  2023cites this paper
• Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension

  2023cites this paper
• Metabolic Approaches for the Treatment of Dilated Cardiomyopathy

  2023cites this paper
• Preparation, characterization, and antioxidant and antiapoptotic activities of biosynthesized nano‑selenium by yak-derived Bacillus cereus and chitosan-encapsulated chemically synthesized nano‑selenium.

  2023cites this paper
• The mTOR signaling pathway in cardiac aging

  2023cites this paper
• 1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy

  2023cites this paper
• Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes

  2023cites this paper
• Targeting Mitochondrial Metabolism to Save the Failing Heart

  2023cites this paper
• Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling

  2023cites this paper
• Cardioprotective effect of ultrasound-targeted destruction of Sirt3-loaded cationic microbubbles in a large animal model of pathological cardiac hypertrophy.

  2023cites this paper
• Salivary lipid mediators: Key indexes of inflammation regulation in heart failure disease.

  2023cites this paper
• COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events

  2023cites this paper
• Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.

  2023cites this paper
• Cognitive impairment in patients with heart failure: molecular mechanism and therapy

  2023cites this paper
• Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review

  2023cites this paper
• Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy

  2023cites this paper
• Mitochondrial Oxidative Stress Mediates Bradyarrhythmia in Leigh Syndrome Mitochondrial Disease Mice

  2023cites this paper
• Liraglutide protects against diastolic dysfunction and improves ventricular protein translation

  2023cites this paper
• Long noncoding RNAs in cardiometabolic disorders

  2022cites this paper
• Protein tyrosine phosphatase 1B regulates miR-208b-argonaute 2 association and thyroid hormone responsiveness in cardiac hypertrophy

  2022cites this paper
• PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy.

  2022cites this paper
• Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction

  2022cites this paper
• Roles of autophagy in angiotensin II‐induced cardiomyocyte apoptosis

  2022cites this paper
• Direct cardiac effects of SGLT2 inhibitors

  2022cites this paper
• LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats

  2022cites this paper
• Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes

  2022cites this paper
• CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome

  2022cites this paper
• Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome

  2022cites this paper
• Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling

  2022cites this paper
• Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease

  2022cites this paper
• Effects of chronic intermittent hypoxia on left cardiac function in young and aged mice.

  2022cites this paper
• Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease

  2022cites this paper
• Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

  2022cites this paper